Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

celgene limited, a bristol myers squibb company - thalidomide 200mg - capsule - 200 mg - active: thalidomide 200mg excipient: gelatin magnesium stearate pregelatinised maize starch - · thalomid in combination with melphalan and prednisone is indicated for the treatment of patients with untreated multiple myeloma aged 65 years or older, or ineligible for high dose chemotherapy. · thalomid in combination with dexamethasone is indicated for induction therapy prior to high dose chemotherapy with autologous stem cell rescue, for the treatment of patients with untreated multiple myeloma. ·thalomid, as monotherapy, is indicated for the treatment of multiple myeloma after failure of standard therapies.

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

celgene limited, a bristol myers squibb company - thalidomide 50mg - capsule - 50 mg - active: thalidomide 50mg excipient: gelatin magnesium stearate pregelatinised maize starch - · thalomid in combination with melphalan and prednisone is indicated for the treatment of patients with untreated multiple myeloma aged 65 years or older, or ineligible for high dose chemotherapy. · thalomid in combination with dexamethasone is indicated for induction therapy prior to high dose chemotherapy with autologous stem cell rescue, for the treatment of patients with untreated multiple myeloma. ·thalomid, as monotherapy, is indicated for the treatment of multiple myeloma after failure of standard therapies.

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

celgene corporation - thalidomide (unii: 4z8r6ors6l) (thalidomide - unii:4z8r6ors6l) - thalidomide 50 mg - thalomid in combination with dexamethasone is indicated for the treatment of patients with newly diagnosed multiple myeloma (mm) [see clinical studies (14.1)] . thalomid is indicated for the acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (enl). thalomid is not indicated as monotherapy for such enl treatment in the presence of moderate to severe neuritis. thalomid is also indicated as maintenance therapy for prevention and suppression of the cutaneous manifestations of enl recurrence [see clinical studies (14.2)]. thalomid is contraindicated in females who are pregnant. thalomid can cause fetal harm when administered to a pregnant female [see boxed warning, warnings and precautions (5.1) and use in specific populations (8.1)] . thalomid is a powerful human teratogen, inducing a high frequency of severe and life-threatening birth defects, even after a single dose [see boxed warning] . mortality at or shortly after birth has been reported in about 40% of infants.

Malaysia - Englisch - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pharm-d sdn. bhd. - thalidomide -

Malaysia - Englisch - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

zulat pharmacy sdn. bhd. - clofazimine -

Singapur - Englisch - HSA (Health Sciences Authority)

pharm-d singapore private limited - thalidomide - capsule - thalidomide 50mg

Kanada - Englisch - Health Canada

celgene inc - thalidomide - capsule - 50mg - thalidomide 50mg - immunomodulatory agents

Kanada - Englisch - Health Canada

celgene inc - thalidomide - capsule - 100mg - thalidomide 100mg - immunomodulatory agents

Kanada - Englisch - Health Canada

celgene inc - thalidomide - capsule - 150mg - thalidomide 150mg - immunomodulatory agents

Kanada - Englisch - Health Canada

celgene inc - thalidomide - capsule - 200mg - thalidomide 200mg - immunomodulatory agents